Exciting Applications of Single Chain Trimers of MHC-I Molecules

Overview

Journal Cancer Immunol Immunother

Specialties Allergy & Immunology
Oncology
Pharmacology

Date 2005 Nov 2

PMID 16261380

Citations 7

Authors

Ted H Hansen

Lonnie Lybarger

Affiliations

Soon will be listed here.

Citing Articles

Intrinsic Folding Properties of the HLA-B27 Heavy Chain Revealed by Single Chain Trimer Versions of Peptide-Loaded Class I Major Histocompatibility Complex Molecules.

Lenart I, Truong L, Nguyen D, Rasiukiene O, Tsao E, Armstrong J Front Immunol. 2022; 13:902135.

PMID: 35958592 PMC: 9359109. DOI: 10.3389/fimmu.2022.902135.

High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape.

Obermair F, Renoux F, Heer S, Lee C, Cereghetti N, Loi M Sci Adv. 2022; 8(17):eabl5394.

PMID: 35486722 PMC: 9054008. DOI: 10.1126/sciadv.abl5394.

Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.

Kim S, Zuiani A, Carrero J, Hansen T Vaccine. 2012; 30(12):2178-86.

PMID: 22285270 PMC: 3288962. DOI: 10.1016/j.vaccine.2012.01.012.

Dimeric MHC-peptides inserted into an immunoglobulin scaffold as new immunotherapeutic agents.

Goldberg B, Bona C J Cell Mol Med. 2011; 15(9):1822-32.

PMID: 21435177 PMC: 3918039. DOI: 10.1111/j.1582-4934.2011.01319.x.

Properties and applications of single-chain major histocompatibility complex class I molecules.

Kotsiou E, Brzostek J, Gould K Antioxid Redox Signal. 2010; 15(3):645-55.

PMID: 21126187 PMC: 3125553. DOI: 10.1089/ars.2010.3694.

References

White J, Crawford F, Fremont D, Marrack P, Kappler J . Soluble class I MHC with beta2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma. J Immunol. 1999; 162(5):2671-6. View

Dela Cruz C, Tan R, Rowland-Jones S, Barber B . Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications. Int Immunol. 2000; 12(9):1293-302. DOI: 10.1093/intimm/12.9.1293. View

Jaramillo A, Narayanan K, Campbell L, Benshoff N, Lybarger L, Hansen T . Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat. 2004; 88(1):29-41. DOI: 10.1007/s10549-004-8918-1. View

Kim S, Poursine-Laurent J, Truscott S, Lybarger L, Song Y, Yang L . Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005; 436(7051):709-13. DOI: 10.1038/nature03847. View

Uger R, Chan S, Barber B . Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. J Immunol. 1999; 162(10):6024-8. View

Crew M, Cannon M, Phanavanh B, Garcia-Borges C . An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Mol Immunol. 2005; 42(10):1205-14. DOI: 10.1016/j.molimm.2004.11.013. View

Greten T, Korangy F, Neumann G, Wedemeyer H, Schlote K, Heller A . Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. J Immunol Methods. 2002; 271(1-2):125-35. DOI: 10.1016/s0022-1759(02)00346-0. View

Mottez E, Langlade-Demoyen P, Gournier H, Martinon F, Maryanski J, Kourilsky P . Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic. J Exp Med. 1995; 181(2):493-502. PMC: 2191874. DOI: 10.1084/jem.181.2.493. View

Chung D, Dorfman J, Plaksin D, Natarajan K, Belyakov I, Hunziker R . NK and CTL recognition of a single chain H-2Dd molecule: distinct sites of H-2Dd interact with NK and TCR. J Immunol. 1999; 163(7):3699-708. View

10.

Primeau T, Myers N, Yu Y, Lybarger L, Wang X, Truscott S . Applications of major histocompatibility complex class I molecules expressed as single chains. Immunol Res. 2005; 32(1-3):109-21. DOI: 10.1385/ir:32:1-3:109. View

11.

Yu Y, Netuschil N, Lybarger L, Connolly J, Hansen T . Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J Immunol. 2002; 168(7):3145-9. DOI: 10.4049/jimmunol.168.7.3145. View

12.

Huang C, Peng S, He L, Tsai Y, Boyd D, Hansen T . Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope. Gene Ther. 2005; 12(15):1180-6. PMC: 3179388. DOI: 10.1038/sj.gt.3302519. View

13.

Toshitani K, Braud V, Browning M, Murray N, McMichael A, Bodmer W . Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes. Proc Natl Acad Sci U S A. 1996; 93(1):236-40. PMC: 40213. DOI: 10.1073/pnas.93.1.236. View

14.

Mage M, Lee L, Ribaudo R, Corr M, Kozlowski S, McHugh L . A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity. Proc Natl Acad Sci U S A. 1992; 89(22):10658-62. PMC: 50400. DOI: 10.1073/pnas.89.22.10658. View

15.

Lybarger L, Yu Y, Miley M, Fremont D, Myers N, Primeau T . Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. J Biol Chem. 2003; 278(29):27105-11. DOI: 10.1074/jbc.M303716200. View

16.

Uger R, Barber B . Creating CTL targets with epitope-linked beta 2-microglobulin constructs. J Immunol. 1998; 160(4):1598-605. View

17.

Choudhuri K, Wiseman D, Brown M, Gould K, Anton van der Merwe P . T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature. 2005; 436(7050):578-82. DOI: 10.1038/nature03843. View

18.

Vest Hansen N, Ostergaard Pedersen L, Stryhn A, Buus S . Phage display of peptide / major histocompatibility class I complexes. Eur J Immunol. 2001; 31(1):32-8. DOI: 10.1002/1521-4141(200101)31:1<32::aid-immu32>3.0.co;2-6. View

19.

Oved K, Lev A, Noy R, Segal D, Reiter Y . Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes. Cancer Immunol Immunother. 2005; 54(9):867-79. PMC: 11032774. DOI: 10.1007/s00262-005-0666-5. View